Medical/Pharmaceuticals

Latest International Study Shows Aesthetic Surgery Continues to Rise Worldwide

Total surgical and nonsurgical procedures increased by 5.4% in 2018 HANOVER, New Hampshire, Dec. 4, 2019 /PRNewswire/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of their annual International Survey on Aesthetic/Cosmetic Procedures today, which showed a...

2019-12-04 01:00 345

United Imaging, BAMF Health Bring Bold Vision to Life: Global Strategic Partnership Advances Theranostics and Precision Medicine

HOUSTON, Dec. 3, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced today a global, strategic partnership with BAMF Health, an organization that is achieving AI-enabled precision medicine through molecular imaging and theranostic...

2019-12-03 21:00 197

Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US

TAIPEI, Dec. 3, 2019 /PRNewswire/ -- Opioid misuse, addiction, and overdoses have caused significant social and economic burdens leading to the opioid crisis. LT1001 (brand name Naldebain®) is a prodrug of nalbuphine, an abuse-free analgesic that has been marketed worldwide for decades. Naldebain...

2019-12-03 17:36 216

Continuing the Resplendence with 20 Years' Glory, CPhI China Welcomes the Golden Year of Chinese Pharma

SHANGHAI, Dec. 3, 2019 /PRNewswire/ -- As a world-renowned vertical trade and exchange event of the pharmaceutical industry, CPhI & P-MEC China 2020 will take place at Shanghai New International Expo Centre (SNIEC)June 22-24, 2020. The exhibition will reach a scale of 210,000m2, facilitate over 3...

2019-12-03 16:54 325

QBiotics Announces First Patient Dosed in its Phase I/II Clinical Trial of Tigilanol Tiglate for Head and Neck Cancer

* First patient successfully dosed in QBiotics' Phase I/II clinical trial of tigilanol tiglate in patients with Head and Neck Squamous Cell Carcinoma (HNSCC) * Tigilanol tiglate is a novel, small molecule that is being tested as a single injection treatment for solid tumours * The Phase I/II ...

2019-12-03 07:11 452

New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority

* NERLYNX® (neratinib) now approved in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy * NERLYNX is the first therapy in the Specialised Therapeutics' portfolio approved inSE Asia * Five-year follow up data show NERLYNX reduces risk of invasive disease...

2019-12-03 05:30 260

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:28 369

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:18 312

Concord Medical Announces Changes to the Board

BEIJING, Dec. 2, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced the resignation of Mr. Sha...

2019-12-02 17:39 4388

Taiwan Healthcare Industry Players Seek to Explore Opportunities in Malaysia

KUALA LUMPUR, Malaysia, Dec. 2, 2019 /PRNewswire/ -- Delegates from 7 premier healthcare services providers fromTaiwan met up with their Malaysian counterparts on 2nd December in Kuala Lumpur in a bid to promote Taiwan's medical care services internationally. Amongst the Malaysian participants ar...

2019-12-02 17:30 385

Innovent Presents Co-developed Cancer-Fighting Tyvyt(R) (Sintilimab Injection) at CIIE 2019 with Eli Lilly

SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics (01801.HK), a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Tyvyt® (generic name: sintilimab injection), a fully human anti-programmed cell death protein 1 (anti-PD-1) monoclonal anti...

2019-12-02 09:37 3429

Innovent Biologics Announces FDA Acceptance of NDA for Pemigatinib in Patients with Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

SUZHOU, China, Dec. 2, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today a...

2019-12-02 08:00 581

United Imaging Sends a Big Message with New Launches, Collaborations

HOUSTON, Dec. 1, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has begun unveiling new technology and strategic collaborations that showcase significant commitment to U.S. market growth. The company had already announced an agreement...

2019-12-02 02:30 433

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication

SHENZHEN, China, Nov. 29, 2019 /PRNewswire/ -- On November 29, 2019, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company's lead innovative product Epidaza® (Chidamide), an oral subtype-selective histone deacetylase (HDAC) inhib...

2019-11-29 20:22 920

Euromedicom Inaugurates the First Edition of FACE ASEAN in Bali, Indonesia - Southeast Asia

KUALA LUMPUR, Malaysia, Nov. 29, 2019 /PRNewswire/ -- The inaugural of FACE ASEAN is scheduled from 12-13 September 2020 at the Nusa Dua Convention Center inBali, Indonesia. FACE ASEAN is the newest addition to the Euromedicom family, is a meeting intended to meet the needs of the medical aesthet...

2019-11-29 10:32 691

Ascletis successfully obtained Pharmaceutical Trade License and GSP Certificate, formed a Complete Commercial Layout

HANGZHOU, China and SHAOXING, China, Nov. 29, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Ascle...

2019-11-29 08:00 788

Concord Medical Schedules 2019 Annual Meeting of Shareholders

BEIJING, Nov. 28, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced that it will hold its 201...

2019-11-28 17:30 5204

Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL)

SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced...

2019-11-28 12:10 1134

Mundipharma CEO Raman Singh Wins Executive of The Year at SBR Management Excellence Awards

SINGAPORE, Nov. 28, 2019 /PRNewswire/ -- Mundipharma CEO, Raman Singh has been named Executive of the Year for the third year running by the Singapore Business Review's (SBR) Management Excellence Awards, held at Conrad Centennial Singapore on 26 November. SBR's Management Excellence Awards hono...

2019-11-28 12:00 550

VISTA Eye Specialist unveils gaming technology for eye treatment

KUALA LUMPUR, Malaysia, Nov. 28, 2019 /PRNewswire/ -- VISTA Eye Specialist (VISTA), one of the leading Eye Specialists inMalaysia, announces the launch of a neurorehabilitation software - Vivid Vision - that uses virtual reality (VR) games to help binocular vision disorders such as lazy or squint...

2019-11-28 08:00 748
12345 ... 360